lithium has been researched along with Muscle Weakness in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cooke, J; McNamara, B; Merwick, A; Neligan, A; Sweeney, BJ | 1 |
Elsais, A; Kerty, E; Melien, Ø; Popperud, TH | 1 |
Davis, SM; Lang, EJ | 1 |
3 other study(ies) available for lithium and Muscle Weakness
Article | Year |
---|---|
Acute neuropathy in setting of diarrhoeal illness and hyponatraemia due to lithium toxicity.
Topics: Action Potentials; Adult; Antimanic Agents; Bipolar Disorder; Cranial Nerve Diseases; Diarrhea; Electromyography; Female; Humans; Hyponatremia; Lithium; Lithium Compounds; Muscle Weakness; Neural Conduction; Neurologic Examination; Sensory Receptor Cells | 2011 |
[Drugs that may trigger or exacerbate myasthenia gravis].
Topics: Acetylcholine; Adrenal Cortex Hormones; Adrenergic beta-Antagonists; Aminoglycosides; Analgesics; Anesthetics; Anti-Infective Agents; Anticonvulsants; Botulinum Toxins; Contraindications; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lithium; Macrolides; Magnesium Sulfate; Muscle Weakness; Myasthenia Gravis; Neuromuscular Junction; Penicillamine; Receptors, Cholinergic; Vaccines | 2013 |
Lithium neurotoxicity: the development of irreversible neurological impairment despite standard monitoring of serum lithium levels.
Topics: Adult; Bipolar Disorder; Cerebellar Ataxia; Dose-Response Relationship, Drug; Dysarthria; Humans; Leg; Lithium; Male; Muscle Weakness | 2002 |